Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

SiteOne Therapeutics
960 Technology Blvd., STE 224
Bozeman, MT 59718
Phone: 650-260-8921
http://www.site1therapeutics.com/

SiteOne Therapeutics, headquartered in Bozeman, Montana, was founded with technology invented at Stanford University that represents a potential revolutionary advancement in the treatment of acute and chronic pain. The company's therapeutic candidates are highly selective sodium ion channel 1.7 (NaV1.7) inhibitors based on naturally occurring small molecules. Given the critical role NaV1.7 plays in the generation and conduction of pain signals, combined with the urgent need for new, non-opioid pain therapies, SiteOne is focused on advancing its lead product for the treatment of moderate to severe pain. Additional opportunities with the company's technology include long-acting analgesics, PET imaging diagnostics for pain and other pain indications. SiteOne owns worldwide development and commercialization rights to its development programs through an exclusive license from Stanford University.

Key Contact
Name
Stan E. Abel
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
07/15/15 undisclosed Biobrit
Mission Bay Capital
Next Frontier Capital
Sears Capital Management
Z Investments
undisclosed
01/09/17 $15,000,000 Series B Amgen Business Development
Biobrit
Mission Bay Capital
Next Frontier Capital
Sears Capital Management
Z Investments
undisclosed


Featured Reading